These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3358904)

  • 41. Relationships between DNA damage and growth inhibition induced by topoisomerase II-interfering drugs in doxorubicin-sensitive and -resistant rat glioblastoma cells.
    de Tinguy-Moreaud E; Pourquier P; Montaudon D; Robert J
    Anticancer Res; 1994; 14(1A):99-103. PubMed ID: 8166463
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization in vitro and in vivo of progressively adriamycin-resistant B16-BL6 mouse melanoma cells.
    Ganapathi R; Grabowski D; Schmidt H; Bell D; Melia M
    Cancer Res; 1987 Jul; 47(13):3464-8. PubMed ID: 2884031
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cross resistance relevance of the chemical structure of different anthracyclines in multidrug resistant cells.
    Tapiero H; Nguyen-Ba G; Lampidis TJ
    Pathol Biol (Paris); 1994 Apr; 42(4):328-37. PubMed ID: 7808786
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trifluoperazine modulation of resistance to the topoisomerase II inhibitor etoposide in doxorubicin resistant L1210 murine leukemia cells.
    Kamath N; Grabowski D; Ford J; Drake F; Kerrigan D; Pommier Y; Ganapathi R
    Cancer Commun; 1991 Feb; 3(2):37-44. PubMed ID: 1995027
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of DNA breakage in cytotoxicity of doxorubicin, 9-deoxydoxorubicin, and 4-demethyl-6-deoxydoxorubicin in murine leukemia P388 cells.
    Capranico G; De Isabella P; Penco S; Tinelli S; Zunino F
    Cancer Res; 1989 Apr; 49(8):2022-7. PubMed ID: 2702645
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative effects of doxorubicin and 4'-epi-doxorubicin on nucleic acid metabolism and cytotoxicity in a human tumor cell line.
    Cantoni O; Sestili P; Cattabeni F; Geroni C; Giuliani F
    Cancer Chemother Pharmacol; 1990; 27(1):47-51. PubMed ID: 1700932
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Anthracycline transport in sensitive and resistant leukemia cells].
    Erttmann R; Erb N; Forcadell de Dios P; Neurath C; Looft G; Landbeck G
    Klin Padiatr; 1989; 201(1):40-5. PubMed ID: 2704176
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin.
    Lau DH; Lewis AD; Ehsan MN; Sikic BI
    Cancer Res; 1991 Oct; 51(19):5181-7. PubMed ID: 1717140
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative cytotoxicity, DNA synthesis inhibition and drug incorporation of eight anthracyclines in a model of doxorubicin-sensitive and -resistant rat glioblastoma cells.
    Schott B; Robert J
    Biochem Pharmacol; 1989 Jan; 38(1):167-72. PubMed ID: 2910297
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Calmodulin inhibitor trifluoperazine in combination with doxorubicin induces the selection of tumour cells with the multidrug resistant phenotype.
    Kamath N; Grabowski D; Ford J; Ganapathi R
    Br J Cancer; 1993 Jun; 67(6):1203-8. PubMed ID: 8099806
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of the efficacy of a phenothiazine and a bisquinaldinium calmodulin antagonist against multidrug-resistant P388 cell lines.
    Hait WN; Pierson NR
    Cancer Res; 1990 Feb; 50(4):1165-9. PubMed ID: 2297765
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evidence of DNA topoisomerase II-dependent mechanisms of multidrug resistance in P388 leukemia cells.
    De Isabella P; Capranico G; Binaschi M; Tinelli S; Zunino F
    Mol Pharmacol; 1990 Jan; 37(1):11-6. PubMed ID: 2153905
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reversal of multidrug resistance in vivo by dietary administration of the phytochemical indole-3-carbinol.
    Christensen JG; LeBlanc GA
    Cancer Res; 1996 Feb; 56(3):574-81. PubMed ID: 8564974
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transport mechanism of anthracycline derivatives in human leukemia cell lines: uptake and efflux of pirarubicin in HL60 and pirarubicin-resistant HL60 cells.
    Nagasawa K; Natazuka T; Chihara K; Kitazawa F; Tsumura A; Takara K; Nomiyama M; Ohnishi N; Yokoyama T
    Cancer Chemother Pharmacol; 1996; 37(4):297-304. PubMed ID: 8548874
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterisation of adriamycin- and amsacrine-resistant human leukaemic T cell lines.
    Snow K; Judd W
    Br J Cancer; 1991 Jan; 63(1):17-28. PubMed ID: 1989661
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changes in subcellular doxorubicin distribution and cellular accumulation alone can largely account for doxorubicin resistance in SW-1573 lung cancer and MCF-7 breast cancer multidrug resistant tumour cells.
    Schuurhuis GJ; van Heijningen TH; Cervantes A; Pinedo HM; de Lange JH; Keizer HG; Broxterman HJ; Baak JP; Lankelma J
    Br J Cancer; 1993 Nov; 68(5):898-908. PubMed ID: 8105865
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reversal of doxorubicin resistance in multidrug resistant melanoma cells in vitro and in vivo by dipyridamole.
    Desai PB; Duan J; Sridhar R; Damle BD
    Methods Find Exp Clin Pharmacol; 1997 May; 19(4):231-9. PubMed ID: 9228648
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationships among cell survival, O6-alkylguanine-DNA alkyltransferase activity, and reactivation of methylated adenovirus 5 and herpes simplex virus type 1 in human melanoma cell lines.
    Maynard K; Parsons PG; Cerny T; Margison GP
    Cancer Res; 1989 Sep; 49(17):4813-7. PubMed ID: 2547518
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro reversal of doxorubicin resistance by the tiapamil analog RO 11-2933 in human ovarian cancer cells.
    Mazzoni A
    Tumori; 1990 Feb; 76(1):69-72. PubMed ID: 2321277
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Single-strand DNA breaks induced by chromophore-modified anthracyclines in P388 leukemia cells.
    Capranico G; Soranzo C; Zunino F
    Cancer Res; 1986 Nov; 46(11):5499-503. PubMed ID: 3463414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.